母系遗传性糖尿病伴耳聋相关视网膜病变进展的预测参数评估
结果显示平均进展速率为2.33 mm²/年,且依赖基线病灶大小;性别、年龄和萎缩灶数量可预测未来进展速率并减少模拟干预试验所需样本量。
要点
- AF成像可追踪所有眼的进行性RPE萎缩,平均进展速率2.33 mm²/年。
- 基线病灶大小与进展速率相关(+0.04 mm²/年/mm²,P<.001),平方根转换后消失。
- 性别、年龄和萎缩灶数量可预测进展速率,交叉验证平均绝对误差0.13 mm/年。
核心结论
- AF成像可追踪所有MIDD相关RPE萎缩眼的进展,形状描述因素和基线特征具有显著预后价值。
研究设计与样本
- 由2名独立阅片者纵向测量病灶大小和形状描述参数,采用线性混合效应模型预测病灶扩大速率并模拟干预试验样本量。
主要发现
- 平均随访时间4.27年,RPE萎缩平均进展速率为2.33 mm²/年。
- 进展速率依赖基线病灶大小(+0.04 [0.02-0.07] mm²/年/mm²,P<.001),平方根转换后该依赖消失。
- 观察期间多数患者黄斑中心凹保持未受累;当中心凹受累时,视力下降滞后于AF图像上的中心RPE萎缩。
- 性别、年龄和萎缩灶数量可预测未来进展速率,交叉验证平均绝对误差为0.13 mm/年。
关键数值与推荐
- 基于性别、年龄和萎缩灶数量的预测模型交叉验证平均绝对误差为0.13 mm/年。
临床怎么用
- 可利用AF成像纵向监测MIDD相关RPE萎缩进展。
- 基线病灶大小、性别、年龄和萎缩灶数量可用于预后判断和干预试验的受试者选择及样本量估算。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the prognostic value of demographic, functional, and imaging parameters on retinal pigment epithelium (RPE) atrophy progression secondary to maternally inherited diabetes and deafness (MIDD) and to evaluate the application of these factors in clinical trial design. DESIGN: Retrospective observational case series. METHODS: Thirty-five eyes of 20 patients (age range, 24.9-75.9 years) with genetically proven MIDD and demarcated RPE atrophy on serial fundus autofluorescence (AF) images were included. Lesion size and shape-descriptive parameters were longitudinally determined by 2 independent readers. A linear mixed-effect model was used to predict the lesion enlargement rate based on baseline variables. Sample size calculations were performed to model the power in a simulated interventional study. RESULTS: The mean follow-up time was 4.27 years. The mean progression rate of RPE atrophy was 2.33 mm2/year, revealing a dependence on baseline lesion size (+0.04 [0.02-0.07] mm2/year/mm2, P < .001), which was absent after square root transformation. The fovea was preserved in the majority of patients during the observation time. In the case of foveal involvement, the loss of visual acuity lagged behind central RPE atrophy in AF images. Sex, age, and number of atrophic foci predicted future progression rates with a cross-validated mean absolute error of 0.13 mm/year and to reduce the required sample size for simulated interventional trials. CONCLUSIONS: Progressive RPE atrophy could be traced in all eyes using AF imaging. Shape-descriptive factors and patients' baseline characteristics had significant prognostic value, guiding appropriate subject selection and sample size in future interventional trial design.
引用
- Müller PL, Treis T, Pfau M, et al. Progression of Retinopathy Secondary to Maternally Inherited Diabetes and Deafness - Evaluation of Predicting Parameters. Am J Ophthalmol. 2020. PMID: 31987901. doi:10.1016/j.ajo.2020.01.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。